How much does psilocybin therapy cost?

Psilocybin therapy is not yet FDA-approved in the US, so costs are through Oregon's licensed service center model or international retreats. Oregon licensed facilitator sessions cost approximately $1,500–$3,500 for a single session including preparation and integration. Multi-day retreat programs cost $3,000–$12,000. Colorado's similar framework (licensed in 2025–2026) is comparable. International psilocybin retreats in the Netherlands or Jamaica run $2,500–$8,000.

How can I get psychedelic therapy for free?

Clinical trials are the primary way to access psychedelic therapy at no cost. Active trials for psilocybin (COMPASS, Usona, Hopkins, NYU), MDMA (MAPS Phase 3 completion studies), and ibogaine (Stanford veteran study) provide free therapy plus compensation. Search ClinicalTrials.gov for open enrollment. Some nonprofit organizations (MAPS, Multidisciplinary Association for Psychedelic Studies) also offer sliding-scale or subsidized access programs.

How much does an ayahuasca retreat cost?

Ayahuasca retreats in Peru typically cost $1,500–$4,000 for a 7–10 day program including accommodation, ceremonies, and facilitator support. Premium retreat centers with Western comforts and medical staff charge $4,000–$10,000+. Jamaica-based retreats (legal, closer to the US) cost $2,000–$6,000. Budget options in Peru start around $800–$1,500 but often lack medical screening.

When will psychedelic therapy become affordable?

OOTWOracle predicts costs will decrease significantly once FDA approval enables insurance coverage. After psilocybin FDA approval (predicted 52% probability by 2028), insurance reimbursement would reduce out-of-pocket costs to typical specialty therapy copays ($50–$200/session). Group therapy formats, which are being tested by COMPASS and others, could reduce costs by 60–80% vs. individual sessions.

How Much Does Psychedelic Therapy Cost? 2026 Price Guide

Q: How much does ketamine therapy cost?

Ketamine IV infusions for depression typically cost $400–$800 per session, with treatment protocols requiring 6 infusions over 2–3 weeks for an initial cost of $2,400–$4,800. Some clinics offer maintenance infusions at $300–$500 each. Spravato (esketamine nasal spray, FDA-approved) may be covered by insurance with prior authorization. Intranasal ketamine and at-home ketamine prescriptions (where available) cost less — approximately $200–$400 per month.

Q: Does insurance cover psychedelic therapy?

Currently, insurance covers only Spravato (esketamine) with prior authorization for treatment-resistant depression. Standard ketamine infusions are typically not covered. Psilocybin, MDMA, and other psychedelic therapies are not covered by any US insurance plan as of 2026. OOTWOracle's 8-agent AI predicts 67% probability of insurance coverage for psilocybin-assisted therapy within 2 years of FDA approval.

$400–$800

Ketamine IV per session

$3K–$12K

Psilocybin retreat programs

Clinical trial access (+ compensation)

67%

Oracle: Insurance covers psilocybin within 2yr of FDA approval

Best Way to Access Psychedelic Therapy for Free: Clinical trials. Active Phase 2/3 trials for psilocybin (depression, OCD, addiction), MDMA (PTSD), and ibogaine (veterans) provide free therapy plus compensation of $50–$500. Search ClinicalTrials.gov — many have open enrollment right now.

Ketamine Therapy Cost Breakdown

Ketamine is the only currently legal psychedelic-adjacent therapy widely available in the US. Two pathways exist — IV infusions (off-label, not typically covered) and FDA-approved Spravato nasal spray (may be covered).

💉 IV Ketamine Infusions (Off-Label)

Single infusion (45–60 min) $400–$800

Initial protocol (6 infusions, 2–3 weeks) $2,400–$4,800

Maintenance infusion (monthly) $300–$600

Booster sessions (as needed) $350–$650

Insurance coverage Typically not covered

Integration therapy (recommended add-on) $150–$300/session

💊 Spravato (Esketamine Nasal Spray — FDA Approved)

List price per treatment session $800–$900

Out-of-pocket with insurance (prior auth required) $10–$50/session

Full course without insurance (8 weeks induction) ~$6,400–$7,200

Insurance coverage Yes — with prior authorization for TRD

Spravato requires in-clinic administration (REMS program) — cannot be taken home.

🏠 At-Home Ketamine (Telehealth Prescriptions)

Monthly subscription (oral/sublingual/intranasal) $200–$400/month

Assessment + prescription fee $100–$200 (one-time)

Availability Reduced after 2022–2024 DEA crackdown

Many at-home ketamine providers significantly scaled back following 2022–2024 DEA enforcement actions. Fewer options than 2021–2022.

Psilocybin Therapy Cost Breakdown

Psilocybin therapy is not FDA-approved. Access exists through Oregon's licensed service center model (as of 2023), Colorado's similar framework (phasing in 2025–2026), and international retreats. Underground sessions also exist but carry legal risk.

🍄 Oregon Licensed Psilocybin Service Centers

Preparation session (1 hr) $150–$300

Psilocybin session (6–8 hr facilitated) $1,000–$3,000

Integration session (1 hr) $150–$300

Full program (prep + session + integration) $1,500–$3,500

Multi-session programs (3 sessions) $4,000–$9,000

Insurance coverage Not covered

🌍 International Psilocybin Retreats

Jamaica (legal, short flight from US East Coast) $2,500–$6,000 (3–5 days)

Netherlands (legal grey area) $2,000–$5,000

Mexico (decrim, accessible from Southwest US) $1,500–$4,000

Colorado service centers (phasing in 2025–2026) $1,200–$3,500

MDMA Therapy Cost

MDMA-assisted therapy received a Complete Response Letter (CRL) from the FDA in August 2024, meaning it is not yet approved. MAPS continues Phase 3 extension studies and is preparing a resubmission. No commercial MDMA therapy is legally available in the US outside of clinical trials.

💜 MDMA-Assisted Therapy (When Available)

Clinical trial access (MAPS Phase 3 studies) Free + compensation

Projected commercial cost per MDMA session (post-approval) $3,000–$6,000

Full MAPS protocol (3 MDMA sessions + 15 therapy sessions) Estimated $15,000–$25,000 total

Insurance coverage (post-approval projection) Likely for PTSD — TBD

International (Canada — limited compassionate access) ~$10,000–$15,000 CAD

Ibogaine Therapy Cost

Ibogaine is Schedule I in the US. Legal access requires traveling to licensed clinics in Mexico, Costa Rica, the Netherlands, or other countries. The Stanford University veteran study (Texas-funded) is providing free ibogaine treatment to qualifying veterans.

🌿 Ibogaine Treatment Centers

Mexico (most common destination for Americans) $5,000–$12,000

Costa Rica $6,000–$15,000

Netherlands (highest medical standards) $8,000–$20,000

Stanford veteran study (qualifying veterans only) Free (Texas-funded)

Insurance coverage None — not approved anywhere in US

Ibogaine carries significant cardiac risk — reputable centers require cardiac screening (EKG) and medical supervision. Lower-cost centers with inadequate medical oversight carry higher risk.

Ayahuasca Retreat Cost

🌿 Ayahuasca Retreats

Peru (Amazon or Cusco, 7–10 days) $1,500–$5,000

Peru budget centers (minimal amenities) $800–$1,500

Peru premium retreat centers $4,000–$10,000+

Jamaica (legal, accessible) $2,000–$6,000

Colombia $1,200–$4,000

Costa Rica (legal grey area) $2,000–$6,000

Flight + accommodation (additional) $500–$2,500

The Best Option: Clinical Trials (Free Access)

How to Access Free Psychedelic Therapy: Active Phase 2 and 3 clinical trials provide free therapy, free medical monitoring, and often compensation ($50–$500). Trials are enrolling now at Johns Hopkins, NYU Langone, UCSF, and dozens of other sites across the US. You don't need insurance. Search ClinicalTrials.gov for "psilocybin", "MDMA", or "ketamine" + your condition + "recruiting".

Trial	Substance	Condition	Sites	Status
COMPASS Pathways Phase 2b/3	Psilocybin	Treatment-Resistant Depression	Multiple US + EU	Enrolling
Usona Institute PSIL201	Psilocybin	Major Depression	Multiple US	Enrolling
NYU Psilocybin for Alcohol Use	Psilocybin	Alcohol Use Disorder	New York, NY	Enrolling
Johns Hopkins Psilocybin OCD	Psilocybin	OCD	Baltimore, MD	Enrolling
MAPS MDMA Extension	MDMA	PTSD	Multiple US	Enrolling
Stanford Ibogaine Veterans	Ibogaine	TBI + PTSD (Veterans)	Stanford, CA	Enrolling

How to Access Psychedelic Therapy Right Now — Cost Pathways

🔬 Clinical Trial

Best option. Free therapy, free monitoring, compensation. Requires meeting eligibility criteria. Search ClinicalTrials.gov.

$400–$800/session

💉 Ketamine IV (US)

Legal, widely available, proven for depression. Not typically covered by insurance. 6-session protocol standard.

Copay ~$10–$50

💊 Spravato (US)

FDA-approved, insurance-covered for TRD with prior auth. Esketamine nasal spray. In-clinic only.

$1,500–$3,500

🍄 Oregon Service Center

Legal psilocybin facilitation in Oregon. Prep + session + integration. No insurance coverage.

$2,500–$6,000

🌴 Jamaica Retreat

Legal psilocybin and ayahuasca. Accessible from East Coast. Multiple licensed retreat operators.

$1,500–$5,000

🌿 Peru Ayahuasca

Most established traditional ayahuasca retreat network. 7–10 day programs. Budget options available.

When Will Costs Come Down? Oracle Predictions

🔮 8-Agent AI Oracle — Cost Reduction Timeline

Insurance covers psilocybin within 2yr of FDA approval

67%

Psilocybin FDA approval by 2028

52%

MDMA therapy insurance-covered by 2030 (post-approval)

44%

Group psilocybin sessions reduce cost by 60%+ vs individual by 2028

58%

Medicare/Medicaid covers psychedelic therapy by 2032

29%

Ibogaine FDA approval (any indication) by 2030

18%

The Insurance Coverage Question

Currently, only Spravato (esketamine) is covered by insurance in the US, and only with prior authorization for treatment-resistant depression. The insurance coverage landscape will shift dramatically if psilocybin receives FDA approval.

The Spravato coverage model is the best template for what comes next. Insurers required: documented TRD diagnosis, 2+ failed antidepressant trials, and REMS-compliant administration. Expect similar requirements for psilocybin — administered in certified facilities, documented indication, prior treatment failure evidence.

OOTWOracle's agents model suggests the key variable isn't FDA approval itself — it's whether psilocybin enters clinical practice with a REMS program similar to Spravato (high monitoring, certified facilities) or a more open prescribing model. High-monitoring models tend to get faster insurance adoption because payers can track outcomes and set utilization controls.

Cost Comparison: Psychedelics vs. Conventional Treatment

Treatment	Cost	Duration	Insurance	Evidence (Depression)
SSRIs/SNRIs (lifetime)	$30–$200/month	Ongoing	✅ Covered	30–40% response
TMS (Transcranial Magnetic)	$6,000–$12,000/course	6 weeks	✅ Covered (TRD)	50–60% response
ECT	$2,500–$5,000 (inpatient)	2–4 weeks	✅ Covered	70–90% response (severe)
Spravato	$800–$900/session	Ongoing	✅ Covered (TRD)	~50% response
Psilocybin therapy (Oregon)	$1,500–$3,500	1–3 sessions	❌ Not covered	67–71% response
MDMA therapy (trial)	$0 (trial)	3 sessions	❌ Not covered	67% PTSD response
Ketamine IV	$2,400–$4,800	6 infusions	❌ Not covered	~60% response

Frequently Asked Questions

How much does ketamine therapy cost? ▼

IV ketamine infusions cost $400–$800 per session. Most protocols require 6 infusions over 2–3 weeks for an initial cost of $2,400–$4,800. Maintenance infusions (monthly) cost $300–$600. FDA-approved Spravato (esketamine nasal spray) may be covered by insurance with prior authorization for treatment-resistant depression.

How much does a psilocybin therapy session cost? ▼

In Oregon's licensed service centers (the only legal US option outside of clinical trials), a full psilocybin program costs $1,500–$3,500 — including preparation, facilitated session (6–8 hours), and integration. Multi-session programs run $4,000–$9,000. International psilocybin retreats in Jamaica or the Netherlands cost $2,500–$8,000 including accommodations.

Does insurance cover psychedelic therapy? ▼

Currently only Spravato (esketamine) is covered, and only with prior authorization for treatment-resistant depression. Standard ketamine infusions, psilocybin therapy, MDMA therapy, and all other psychedelic treatments are not covered by any US insurance plan as of 2026. OOTWOracle predicts 67% probability that insurance covers psilocybin within 2 years of FDA approval.

How can I access psychedelic therapy for free? ▼

Clinical trials are the best option. Active trials at Johns Hopkins, NYU Langone, UCSF, and other sites provide free psilocybin or MDMA therapy plus medical monitoring and compensation ($50–$500). The Stanford ibogaine veteran study provides free treatment for qualifying veterans. Search ClinicalTrials.gov for "psilocybin" or "MDMA" + your condition + "recruiting" to find open enrollment.

How much does an ibogaine treatment cost? ▼

Ibogaine treatment at licensed international clinics costs $5,000–$20,000, with Mexico being the most accessible for Americans ($5,000–$12,000). Always budget for flights, accommodation, and pre-trip cardiac screening. The Stanford veteran study provides free ibogaine treatment for qualifying active/retired military with TBI or PTSD. Never use unlicensed ibogaine without medical supervision — cardiac monitoring is essential.

When will psychedelic therapy be covered by insurance? ▼

OOTWOracle's 8-agent AI gives 52% probability of psilocybin FDA approval by 2028, and 67% probability of insurance coverage within 2 years of approval. If that timeline holds, insurance coverage for psilocybin-assisted therapy could begin as early as 2030–2031. MDMA timeline is longer. Medicare/Medicaid coverage (29% probability by 2032) would be the key event making psychedelic therapy accessible regardless of income.

Related Research

🧠 Psilocybin for Depression 💉 Ketamine Regulation Guide 💊 MDMA Therapy + FDA 🌿 Ibogaine 2026 Hub 🔬 Clinical Trials — How to Enroll 🌿 Ayahuasca Legal Status 🎖️ PTSD + Veterans 📚 All Topics

📡 OOTWOracle — Daily AI predictions on psychedelic medicine regulation

Track the regulatory signals that will determine when costs come down and insurance kicks in.

View Today's Oracle →